336 related articles for article (PubMed ID: 23993855)
21. Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
Nakayama T; Otsuka S; Kobayashi T; Okajima H; Matsumoto K; Hagiya Y; Inoue K; Shuin T; Nakajima M; Tanaka T; Ogura SI
Sci Rep; 2016 Nov; 6():36478. PubMed ID: 27857072
[TBL] [Abstract][Full Text] [Related]
22. Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.
Ogino T; Kobuchi H; Munetomo K; Fujita H; Yamamoto M; Utsumi T; Inoue K; Shuin T; Sasaki J; Inoue M; Utsumi K
Mol Cell Biochem; 2011 Dec; 358(1-2):297-307. PubMed ID: 21748335
[TBL] [Abstract][Full Text] [Related]
23. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
Mansi M; Howley R; Chen B
Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
25. 5-Aminolevulinic acid enhances cell death under thermal stress in certain cancer cell lines.
Chibazakura T; Toriyabe Y; Fujii H; Takahashi K; Kawakami M; Kuwamura H; Haga H; Ogura S; Abe F; Nakajima M; Yoshikawa H; Tanaka T
Biosci Biotechnol Biochem; 2015; 79(3):422-31. PubMed ID: 25346276
[TBL] [Abstract][Full Text] [Related]
26. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
27. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
28. ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD.
Kawai N; Hirohashi Y; Ebihara Y; Saito T; Murai A; Saito T; Shirosaki T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Shichinohe T; Li L; Hirano S; Torigoe T
PLoS One; 2019; 14(5):e0216503. PubMed ID: 31083682
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma.
Zhao SG; Chen XF; Wang LG; Yang G; Han DY; Teng L; Yang MC; Wang DY; Shi C; Liu YH; Zheng BJ; Shi CB; Gao X; Rainov NG
Ann Surg Oncol; 2013 Dec; 20(13):4379-88. PubMed ID: 22688660
[TBL] [Abstract][Full Text] [Related]
30. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
31. The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy via Transporter Regulation.
Kurokawa H; Ito H; Matsui H
Cells; 2019 Aug; 8(8):. PubMed ID: 31426474
[TBL] [Abstract][Full Text] [Related]
32. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
Iinuma S; Bachor R; Flotte T; Hasan T
J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
35. Gefitinib enhances the efficacy of photodynamic therapy using 5-aminolevulinic acid in malignant brain tumor cells.
Sun W; Kajimoto Y; Inoue H; Miyatake S; Ishikawa T; Kuroiwa T
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):42-50. PubMed ID: 23465372
[TBL] [Abstract][Full Text] [Related]
36. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
37. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
38. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
39. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
[TBL] [Abstract][Full Text] [Related]
40. Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine.
Anderson CM; Jevons M; Thangaraju M; Edwards N; Conlon NJ; Woods S; Ganapathy V; Thwaites DT
J Pharmacol Exp Ther; 2010 Jan; 332(1):220-8. PubMed ID: 19789362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
